The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone

BACKGROUND: The standard of care for metastatic gastric cancer (MGC) is systemic chemotherapy which leads to a median survival of 6-15 months. Survival beyond 3 years is rare. For selected groups of patients with limited MGC, retrospective studies have shown improved overall survival following gastr...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Kerkar, Sid P, Kemp, Clinton D, Duffy, Austin, Kammula, Udai S, Schrump, David S, Kwong, King F, Quezado, Martha, Goldspiel, Barry R, Venkatesan, Aradhana, Berger, Ann, Walker, Melissa, Toomey, Mary Ann, Steinberg, Seth M, Giaccone, Guiseppe, Rosenberg, Steven A, Avital, Itzhak
格式: Artigo
語言:Inglês
出版: BioMed Central 2009
主題:
Study protocol
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2803175/
https://ncbi.nlm.nih.gov/pubmed/20030854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-10-121
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍